Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc. (CGEM) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
cgem · stock forecast · 8 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 8 Wall Street analysts in the past 3 months
Buy
8 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$37.00
Consensus
$31.00
+146.4% upside
Low
$28.00
Median: $30 · Last Close: $12.58
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$31.00
146.4% upside
High Target
$37
194.1%
Low Target
$28
122.6%
Current Price
$12.58
as of today
Based on analyst price targets, the CGEM stock price prediction for the next 12 months ranges from $28 to $37. The consensus CGEM price forecast of $31.00 implies 146.4% upside from the current price of $12.58.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $12.13 | ↓ 3.58% |
1-day model range: $12.02–$12.24. Peak: $12.24 (-3.58%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $9 | -26.5% |
| 2028 | $8 | -37.2% |
| 2029 | $7 | -42.2% |
| 2030 | $7 | -44.8% |
| 2031 | — | -46.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · CGEM · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-19 | BTIG | Maintains | Buy→Buy |
| 2026-05-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-05-04 | BTIG | Maintains | Buy→Buy |
| 2026-04-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-04-28 | BTIG | Maintains | Buy→Buy |
| 2026-03-11 | Wedbush | Maintains | Outperform→Outperform |
| 2026-01-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-12-09 | Wedbush | Maintains | Outperform→Outperform |
| 2025-11-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-09-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Cullinan Therapeutics, Inc. (CGEM) stock. Of the recent 43 rating actions, 1 were upgrades and 0 were downgrades. 8 analysts currently cover CGEM.
Analyst Recommendation Trends
CGEM analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$20M
↓ 37.4% YoY
Revenue Next Year
$48M
↑ 142.4% YoY
EPS This Year
$-3.06
EPS Next Year
$-2.43
↓ 20.7% YoY
EPS ForecastReported vs Estimated
Analysts forecast CGEM EPS of $-3.06 for the current fiscal year, based on estimates from 8 analysts. The CGEM revenue forecast is $20M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The CGEM stock forecast is supported by two independent data sources: analyst consensus ratings from 8 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus CGEM price target is $31.00 (+146.4% upside), with an analyst consensus of Buy.
The CGEM short-term stock prediction for tomorrow is $12.13 (-3.58%). The CGEM stock price prediction for 2027 estimates an average of $9. The CGEM stock prediction for 2030 projects a range of $6–$8.
Cullinan Therapeutics, Inc. trades on NASDAQ under the ticker CGEM. The CGEM stock outlook for 2027 is broadly positive, supported by a Buy consensus among 100% of covering analysts.
Frequently asked questions
CGEM forecast · 8 questionsAccording to 8 Wall Street analysts, the average 12-month CGEM price target is $31.00, with a high forecast of $37.00 and a low of $28.00. The median price target is shown in the chart above when available. This implies +146.4% potential upside from the current price of $12.58.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.